Active Ingredient History

  • Now
Doxifluridine is a second generation nucleoside analog prodrug developed by Roche and used as a cytostatic agent in chemotherapy in several Asian countries including China and South Korea. Doxifluridine is not FDA-approved for use in the USA. It is currently being evaluated in several clinical trials as a stand-alone or combination therapy treatment.   Wikipedia

  • SMILES: C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=C(F)C(=O)NC2=O
  • Mol. Mass: 246.19
  • ALogP: -1.69
  • ChEMBL Molecule:
More Chemistry
5'-deoxy-5-fluorouridine | 5'-deoxy-5'-fluorouridine | 5-dfur | 5'-dfur | 5'-fluoro-5'-deoxyuridine | doxfluridine | doxifluridine | doxyfluridine | flutron | furtulon | ro 21-9738 | uridine-5'-deoxy-5-fluoro-


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue